Zobrazeno 1 - 10
of 15
pro vyhledávání: '"FE Millard"'
Autor:
FE Millard, Bercedis Peterson, Heli Collins, VL Brunetto, C Brabyn, Ivor Royston, R B Weiss, FR Davey, DB Duggan, RA Newman
Publikováno v:
Blood. 82:1239-1246
The markers, CD11b, CD11c, CD14, CD21, CD23, CD25, CD38, and FMC7 were correlated with morphologic and other laboratory and clinical characteristics of 127 patients with untreated CD5+ chronic lymphocytic leukemia (CLL). Only CD38 and CD21 were signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d17bdc18914d11c31d6bd9a7c569334
https://doi.org/10.1182/blood.v82.4.1239.1239
https://doi.org/10.1182/blood.v82.4.1239.1239
Autor:
Pan E; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Shaya J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Madlensky L; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Randall JM; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Javier-Desloges J; Department of Urology, University of California San Diego, La Jolla, CA, USA., Millard FE; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Rose B; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA., Parsons JK; Department of Urology, University of California San Diego, La Jolla, CA, USA., Nielsen SM; Invitae Corporation, San Francisco, CA, USA., Hatchell KE; Invitae Corporation, San Francisco, CA, USA., Esplin ED; Invitae Corporation, San Francisco, CA, USA., Nussbaum RL; Invitae Corporation, San Francisco, CA, USA., Weise N; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Murphy J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Martinez ME; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., McKay RR; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Sep; Vol. 25 (3), pp. 561-567. Date of Electronic Publication: 2022 Feb 28.
Autor:
Pan E; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Shaya J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Madlensky L; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Randall JM; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Javier-Desloges J; Department of Urology, University of California San Diego, La Jolla, CA, USA., Millard FE; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Rose B; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA., Parsons JK; Department of Urology, University of California San Diego, La Jolla, CA, USA., Nielsen SM; Invitae Corporation, San Francisco, CA, USA., Hatchell KE; Invitae Corporation, San Francisco, CA, USA., Esplin ED; Invitae Corporation, San Francisco, CA, USA., Nussbaum RL; Invitae Corporation, San Francisco, CA, USA., Weise N; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Murphy J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Martinez ME; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., McKay RR; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Sep; Vol. 25 (3), pp. 599.
Autor:
Field CA; UC San Diego School of Medicine, La Jolla, CA., Cotta BH; UC San Diego School of Medicine, La Jolla, CA., Jimenez J; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH., Lane BR; Spectrum Health, Grand Rapids, MI., Yim K; UC San Diego School of Medicine, La Jolla, CA., Lee HJ; UC San Diego School of Medicine, La Jolla, CA., Ryan ST; UC San Diego School of Medicine, La Jolla, CA., Hamilton ZA; UC San Diego School of Medicine, La Jolla, CA., Patel S; UC San Diego School of Medicine, La Jolla, CA., Wang S; UC San Diego School of Medicine, La Jolla, CA., Kane CJ; UC San Diego School of Medicine, La Jolla, CA., Dey S; Spectrum Health, Grand Rapids, MI., Mckay RR; UC San Diego School of Medicine, La Jolla, CA., Noyes S; Spectrum Health, Grand Rapids, MI., Millard FE; UC San Diego School of Medicine, La Jolla, CA., Rini BI; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH., Campbell SC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH., Derweesh IH; UC San Diego School of Medicine, La Jolla, CA. Electronic address: iderweesh@gmail.com.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2019 Jun; Vol. 17 (3), pp. e505-e512. Date of Electronic Publication: 2019 Jan 30.
Autor:
Antonarakis ES; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC), Baltimore, Maryland., Kibel AS; Brigham and Women's Hospital/Dana-Farber Cancer Center, Boston, Massachusetts., Yu EY; University of Washington and Seattle Cancer Care Alliance, Seattle, Washington., Karsh LI; The Urology Center of Colorado, Denver, Colorado., Elfiky A; Dana-Farber Cancer Institute, Boston, Massachusetts., Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Vogelzang NJ; US Oncology Research Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Corman JM; Virginia Mason Medical Center, Seattle, Washington., Millard FE; Moores UCSD Cancer Center, La Jolla, California., Maher JC; Dendreon Pharmaceuticals Inc., Seattle, Washington., Chang NN; Dendreon Pharmaceuticals Inc., Seattle, Washington., DeVries T; Dendreon Pharmaceuticals Inc., Seattle, Washington., Sheikh NA; Dendreon Pharmaceuticals Inc., Seattle, Washington., Drake CG; Johns Hopkins SKCCC, the Brady Urological Institute and the Bloomberg Kimmel Institute, Baltimore, Maryland. cgd2139@cumc.columbia.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 May 15; Vol. 23 (10), pp. 2451-2459. Date of Electronic Publication: 2016 Nov 10.
Autor:
Milowsky MI; Department of Medicine, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: matt_milowsky@med.unc.edu., Dittrich C; LBI-ACR VIEnna & ACR-ITR VIEnna, Center for Oncology and Haematology, Kaiser Franz Josef-Spital, Vienna, Austria., Durán I; Centro Integral Oncologico Clara Campal, Universidad CEU San Pablo, Madrid, Spain., Jagdev S; St. James's Institute of Oncology, Leeds, UK., Millard FE; Department of Medicine, Division of Hematology-Oncology, University of California, San Diego, San Diego, CA, USA., Sweeney CJ; Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bajorin D; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Cerbone L; Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy., Quinn DI; Division of Medical Oncology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Stadler WM; Department of Medicine, University of Chicago, Chicago, IL, USA., Rosenberg JE; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Lochheed M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sen P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Squires M; Novartis Pharma AG, Basel, Switzerland., Shi M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sternberg CN; Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Dec; Vol. 50 (18), pp. 3145-52. Date of Electronic Publication: 2014 Oct 30.
Autor:
Mirheydar HS; Department of Urology, UC San Diego Health System, San Diego CA, USA., Banapour P; UC San Diego School of Medicine, La Jolla, CA, USA., Massoudi R; UC San Diego School of Medicine, La Jolla, CA, USA., Palazzi KL; Department of Urology, UC San Diego Health System, San Diego CA, USA., Jabaji R; UC San Diego School of Medicine, La Jolla, CA, USA., Reid EG; Department of Medicine, Division of Hematology/Oncology, UC San Diego Health System, San Diego, CA, USA., Millard FE; Department of Medicine, Division of Hematology/Oncology, UC San Diego Health System, San Diego, CA, USA., Kane CJ; Department of Urology, UC San Diego Health System, San Diego CA, USA; UC San Diego School of Medicine, La Jolla, CA, USA and VA San Diego Healthcare System, San Diego, CA, USA., Sur RL; Department of Urology, UC San Diego Health System, San Diego CA, USA; UC San Diego School of Medicine, La Jolla, CA, USA; VA San Diego Healthcare System, San Diego, CA, USA and Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Publikováno v:
International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2014 Nov-Dec; Vol. 40 (6), pp. 772-80.
Autor:
Nath SK; Department of Radiation Oncology, University of California San Diego 3855 Health Sciences Drive, #0843 La Jolla, CA 92093-0843, USA., Sandhu AP, Sethi RA, Jensen LG, Rosario MD, Kane CJ, Parsons JK, Millard FE, Jiang SB, Rice RK, Pawlicki T, Mundt AJ
Publikováno v:
Technology in cancer research & treatment [Technol Cancer Res Treat] 2011 Feb; Vol. 10 (1), pp. 31-7.
Autor:
McFarland JT; Radiation Oncology, Naval Medical Center, San Diego, CA 92134, USA., Kuzma C, Millard FE, Johnstone PA
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 2003 Apr; Vol. 26 (2), pp. 178-83.
Autor:
Lester EP; Lakeland Medical Center, St. Joseph, Michigan, USA. oncology@parrett.net, Petroni GR, Barcos M, Johnson JL, Millard FE, Cooper MR, Omura GA, Frei E 3rd, Peterson BA
Publikováno v:
Cancer investigation [Cancer Invest] 2001; Vol. 19 (5), pp. 447-58.